Liman Qiu

机构：Fujian Medical University, Mengchao Hepatobiliary Hospital · ORCID：0000-0003-4332-1843

发表论文 79 篇 · 总被引 1151 次 · h-index 15

代表论文

• Personalized neoantigen vaccine enhances the therapeutic efficacy of bevacizumab and anti-PD-1 antibody in advanced non-small cell lung cancer (2024 · Cancer Immunology Immunotherapy · 被引 27)
• TLR3 activation enhances abscopal effect of radiotherapy in HCC by promoting tumor ferroptosis (2024 · EMBO Molecular Medicine · 被引 13)
• Rational Design of a Multifunctional Copper‐Cobalt Sulfide Nanozyme for Cholesterol Depletion and Thermo‐Resistant Tumor Ablation (2026 · Advanced Functional Materials · 被引 6)
• Identification of tumor mutations in plasma based on mutation variant frequency change ( MVFC ) (2023 · Molecular Oncology · 被引 4)
• Des-γ-carboxy Prothrombin in hepatocellular carcinoma post-operative recurrence risk evaluation (2025 · Communications Medicine · 被引 3)
• Tumor immune microenvironment states inferred from TLS-associated immune-cell composition stratify prognosis in hepatocellular carcinoma (2026 · Frontiers in Immunology · 被引 1)